170 related articles for article (PubMed ID: 35263376)
21. Prevalence of human papillomavirus and the correlation of HPV infection with cervical disease in Weihai, China.
Yang L; He Z; Huang XY; Liu HN; Tao JY
Eur J Gynaecol Oncol; 2015; 36(1):73-7. PubMed ID: 25872339
[TBL] [Abstract][Full Text] [Related]
22. Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening.
Tay SK; Lin LE; Goh RC
Ann Acad Med Singap; 2017 Jul; 46(7):267-273. PubMed ID: 28821890
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and type distribution of human papillomavirus in women with cervical lesions in Liaoning Province, China.
Liu X; Zhang S; Ruan Q; Ji Y; Ma L; Zhang Y
Int J Gynecol Cancer; 2010 Jan; 20(1):147-53. PubMed ID: 20130516
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and Distribution of Human Papillomavirus Genotypes (1997-2019) and Their Association With Cervical Cancer and Precursor Lesions in Women From Southern Mexico.
Alarcón-Romero LDC; Organista-Nava J; Gómez-Gómez Y; Ortiz-Ortiz J; Hernández-Sotelo D; Del Moral-Hernández O; Mendoza-Catalán MA; Antaño-Arias R; Leyva-Vázquez MA; Sales-Linares N; Antonio-Véjar V; Illades-Aguiar B
Cancer Control; 2022; 29():10732748221103331. PubMed ID: 35608056
[TBL] [Abstract][Full Text] [Related]
25. HPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India.
Mane A; Nirmalkar A; Risbud AR; Vermund SH; Mehendale SM; Sahasrabuddhe VV
PLoS One; 2012; 7(6):e38731. PubMed ID: 22723879
[TBL] [Abstract][Full Text] [Related]
26. The Potential Impact of High-Risk Human Papillomavirus-Negative Cervical Intraepithelial Neoplasia 2+ on Primary Human Papillomavirus Screening.
Iacobone AD; Bottari F; Guerrieri ME; Vidal Urbinati AM; Ghioni M; Spolti N; Pino I; Passerini R; Di Pace RC; Franchi D; Preti EP
Am J Clin Pathol; 2022 Jan; 157(1):130-135. PubMed ID: 34302334
[TBL] [Abstract][Full Text] [Related]
27. Detection of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cancer patients: Sharkia Governorate, Egypt.
Abd El-Azim S; Lotfy M; Omr A
Clin Lab; 2011; 57(5-6):363-71. PubMed ID: 21755827
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus and vaccination in cervical cancer.
Wang KL
Taiwan J Obstet Gynecol; 2007 Dec; 46(4):352-62. PubMed ID: 18182340
[TBL] [Abstract][Full Text] [Related]
29. Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology.
Stoler MH; Wright TC; Parvu V; Yanson K; Cooper CK; Andrews J
Gynecol Oncol; 2019 Apr; 153(1):26-33. PubMed ID: 30638767
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
31. The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia.
Sehnal B; Dusek L; Cibula D; Zima T; Halaska M; Driak D; Slama J
J Clin Virol; 2014 Jan; 59(1):18-23. PubMed ID: 24315797
[TBL] [Abstract][Full Text] [Related]
32. Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.
Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
Int J STD AIDS; 2008 Jun; 19(6):385-92. PubMed ID: 18595876
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus-type distribution in women with and without cervical neoplasia in north India.
Bhatla N; Dar L; Rajkumar Patro A; Kumar P; Pati SK; Kriplani A; Gulati A; Broor S; Iyer VK; Mathur S; Shah KV; Gravitt PE
Int J Gynecol Pathol; 2008 Jul; 27(3):426-30. PubMed ID: 18580322
[TBL] [Abstract][Full Text] [Related]
34. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
[TBL] [Abstract][Full Text] [Related]
35. Human Papillomavirus Genotype Distribution among Thai Women with High-Grade Cervical Intraepithelial Lesions and Invasive Cervical Cancer: a Literature Review.
Kietpeerakool C; Kleebkaow P; Srisomboon J
Asian Pac J Cancer Prev; 2015; 16(13):5153-8. PubMed ID: 26225645
[TBL] [Abstract][Full Text] [Related]
36. Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits.
Meiring TL; Salimo AT; Coetzee B; Maree HJ; Moodley J; Hitzeroth II; Freeborough MJ; Rybicki EP; Williamson AL
Virol J; 2012 Aug; 9():164. PubMed ID: 22897914
[TBL] [Abstract][Full Text] [Related]
37. Current prophylactic HPV vaccines and gynecologic premalignancies.
Harper DM
Curr Opin Obstet Gynecol; 2009 Dec; 21(6):457-64. PubMed ID: 19923989
[TBL] [Abstract][Full Text] [Related]
38. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.
Guan P; Howell-Jones R; Li N; Bruni L; de Sanjosé S; Franceschi S; Clifford GM
Int J Cancer; 2012 Nov; 131(10):2349-59. PubMed ID: 22323075
[TBL] [Abstract][Full Text] [Related]
40. High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine.
Hooi DJ; Lissenberg-Witte BI; de Koning MNC; Pinedo HM; Kenter GG; Meijer CJ; Quint WG
Sex Transm Infect; 2018 Jun; 94(4):263-267. PubMed ID: 29021405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
